Question 1

What are the key details for the project “Focused Pharma”?

Accepted Answer

The project “Focused Pharma” is an infrastructure initiative in the Aerospace & Defense sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Focused Pharma”?

Accepted Answer

The status recorded for “Focused Pharma” is archived.

Question 3

Who are the main government, EPC, and private stakeholders for “Focused Pharma”?

Accepted Answer

Taiyo maps the stakeholders of “Focused Pharma”: government bodies (Biological Technologies Office (BTO), Defence Advanced Research Projects Agency (DARPA), United States Department of Defense (DoD), US Government).

Question 4

Where can I verify the source and access all details for “Focused Pharma”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=320660). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	archived
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	Military service members and veterans face serious occupational trauma; one element in particular relates to the significantly increased risk of acute and chronic neuropsychiatric conditions. Neuropsychiatric conditions in the military are particularly impactful because options for treating them are limited. No therapy currently exists that can deliver rapid relief of neuropsychiatric symptoms and is reasonable for use in a broad spectrum of conditions. Neuropsychiatric conditions are complex, and presentation is highly subject to significant inter-individual variability. Focused Pharma aims to develop new drugs that target specific neurotransmitter receptor signaling modes to deliver near immediate relief that is generalizable across indications and individuals.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Focused Pharma

Project Information FAQ

Project Information